Argon laser radiation of human clots: Differential photoabsorption in red cell rich and red cell poor clots

Since argon laser radiation (454–514 nm) can vaporize human clots, we determined whether the absorption of laser energies can differ among different types of blood clots. Thus we performed sDectrophotometric studies and examined the ability of this laser to penetrate red cell rich and red cell poor...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Thromb. Res.; (United States) 1985-06, Vol.38 (5), p.561-565
Hauptverfasser: Lee, Garrett, Chan, Ming C., Seckinger, Daniel L., Vazquez, Anthony, Rosenthal, Phyllis K., Lee, Kelvin K., Ikeda, Richard M., Reis, Robert L., Hanna, Elias S., Mason, Dean T.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Since argon laser radiation (454–514 nm) can vaporize human clots, we determined whether the absorption of laser energies can differ among different types of blood clots. Thus we performed sDectrophotometric studies and examined the ability of this laser to penetrate red cell rich and red cell poor clots. Fifty-four red cell rich and red cell poor clot samples, varying in depth from 1.8 to 5.0 mm, were subjected to 3, 5 and 7 watts from an argon laser beam. At a given power intensity, the deeper the red cell rich clot, the longer was the time needed to penetrate the clot. The higher the power used, the shorter was the red clot penetration time. In contrast, all power levels used up to 5 minutes did not penetrate any of the varying depths of red cell poor clots. Spectrophotometrically, the red cell rich clot had an absorption curve typical of hemoglobin pigment while the red cell poor clot, in the absence of hemoglobin, had poor absorption between 350 and 600 nm and was unable to absorb argon laser energies. Thus, the argon laser provides a therapeutic modality for human red cell rich clot dissolution but the present approach does not appear to be effective against red cell poor clots.
ISSN:0049-3848
1879-2472
DOI:10.1016/0049-3848(85)90188-4